Maxcyte (MXCT) Interest Coverage Ratio (2020 - 2022)

Maxcyte's (MXCT) quarterly Interest Coverage Ratio came in at 613.7 in Q4 2022, down 823.08% quarter-over-quarter from 66.48 in Q3 2022.

Analysis

Maxcyte (MXCT) Interest Coverage Ratio (2020 - 2022) Analysis & Trends

Maxcyte (MXCT) has reported Interest Coverage Ratio for 3 consecutive years, with 613.7 the latest figure, recorded in Q4 2022.

On a quarterly basis, Interest Coverage Ratio changed N/A year-over-year to 613.7 in Q4 2022; TTM through Dec 2022 was 65.77, a 277.7% decrease from a year earlier, with the FY2022 full-year figure at 215.44, down 1137.07% from the prior year.
Interest Coverage Ratio was 613.7 for Q4 2022 at Maxcyte, down from 66.48 in the prior quarter.
Over five years, Interest Coverage Ratio peaked at 8.45 in Q3 2021 and troughed at 613.7 in Q4 2022.
A 3-year average of 133.55 and a median of 14.04 in 2020 frame the typical range for Interest Coverage Ratio.
The widest YoY moves for Interest Coverage Ratio: up 21.72% in 2021, down 1837.52% in 2021.
Over 3 years, Interest Coverage Ratio stood at 8.49 in 2020, then rose by 0.4% to 8.45 in 2021, then sank by 7160.19% to 613.7 in 2022.
The last three Interest Coverage Ratio figures came in at 613.7 (Q4 2022), 66.48 (Q3 2022), and 8.45 (Q3 2021), per Business Quant data.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Interest Cover (Qtr)
1	Thermo Fisher Scientific	225.48 Bn	221.41 Bn	8.34 Bn	5.20
2	Danaher	144.42 Bn	140.08 Bn	3.61 Bn	10.53
3	Agilent Technologies	40.86 Bn	39.11 Bn	1.04 Bn	15.31
4	Illumina	30.97 Bn	29.80 Bn	770.00 Mn	10.21
5	Revvity	13.85 Bn	12.83 Bn	416.87 Mn	3.46
6	Bio-Techne	11.27 Bn	11.01 Bn	211.39 Mn	34.99
7	Bio-Rad Laboratories	10.11 Bn	8.49 Bn	345.80 Mn	6.00
8	Repligen	9.33 Bn	8.31 Bn	110.04 Mn	2.47
9	10x Genomics	8.77 Bn	8.21 Bn	112.50 Mn	-
10	Maxcyte	131.93 Mn	131.93 Mn	5.60 Mn	-

Historic Data

Download Data